PLIANT THERAPEUTICS, INC. Variable Lease, Cost
PLIANT THERAPEUTICS, INC. (PLRX) reported Variable Lease, Cost of $471.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:VariableLeaseCost · last filed 2026-08-11
- PLIANT THERAPEUTICS, INC. variable lease, cost for the quarter ending 2026-06-30 was $471.00K, a 9.77% decline year-over-year.
- PLIANT THERAPEUTICS, INC. variable lease, cost for the quarter ending 2026-03-31 was $500.00K, a 16.28% increase year-over-year.
- PLIANT THERAPEUTICS, INC. variable lease, cost for the quarter ending 2025-12-31 was $483.00K, a 5.48% decline year-over-year.
- PLIANT THERAPEUTICS, INC. variable lease, cost for the quarter ending 2025-09-30 was $510.00K, a 6.25% increase year-over-year.
- PLIANT THERAPEUTICS, INC. variable lease, cost for fiscal 2025 was $1.95M, a 36.20% increase from fiscal 2024.
- PLIANT THERAPEUTICS, INC. variable lease, cost for fiscal 2024 was $1.43M, a 86.42% increase from fiscal 2023.
- PLIANT THERAPEUTICS, INC. variable lease, cost for fiscal 2023 was $766.00K, a 6.24% increase from fiscal 2022.
- PLIANT THERAPEUTICS, INC. variable lease, cost for fiscal 2022 was $721.00K, a 24.03% decline from fiscal 2021.
| Period end | Variable Lease, Cost 3 month | Variable Lease, Cost 3 month as first filed | Variable Lease, Cost 6 month | Variable Lease, Cost 9 month | Variable Lease, Cost 9 month as first filed | Variable Lease, Cost 12 month | Variable Lease, Cost 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $471.00K 10-Q · filed 2026-08-11 | $971.00K 10-Q · filed 2026-08-11 | $1.45M derived: sum of 3 quarters · filed 2026-08-11 | $1.96M derived: sum of 4 quarters · filed 2026-08-11 | |||
| 2026-03-31 | $500.00K 10-Q · filed 2026-05-11 | $983.00K derived: sum of 2 quarters · filed 2026-05-11 | $1.49M derived: sum of 3 quarters · filed 2026-05-11 | $2.02M derived: sum of 4 quarters · filed 2026-08-11 | |||
| 2025-12-31 | $483.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-11 | $993.00K derived: sum of 2 quarters · filed 2026-03-11 | $1.51M derived: sum of 3 quarters · filed 2026-08-11 | $1.95M 10-K · filed 2026-03-11 | |||
| 2025-09-30 | $510.00K 10-Q · filed 2025-11-06 | $1.03M derived: sum of 2 quarters · filed 2026-08-11 | $1.46M 10-Q · filed 2025-11-06 | $1.97M derived: sum of 4 quarters · filed 2026-08-11 | |||
| 2025-06-30 | $522.00K 10-Q · filed 2026-08-11 | $952.00K 10-Q · filed 2026-08-11 | $1.46M derived: sum of 3 quarters · filed 2026-08-11 | $1.94M derived: sum of 4 quarters · filed 2026-08-11 | |||
| 2025-03-31 | $430.00K 10-Q · filed 2026-05-11 | $941.00K derived: sum of 2 quarters · filed 2026-05-11 | $1.42M derived: sum of 3 quarters · filed 2026-05-11 | $1.70M derived: sum of 4 quarters · filed 2026-05-11 | |||
| 2024-12-31 | $511.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-11 | $991.00K derived: sum of 2 quarters · filed 2026-03-11 | $1.27M derived: sum of 3 quarters · filed 2026-03-11 | $1.43M 10-K · filed 2026-03-11 | |||
| 2024-09-30 | $480.00K 10-Q · filed 2025-11-06 | $760.00K derived: sum of 2 quarters · filed 2025-11-06 | $917.00K 10-Q · filed 2025-11-06 | $1.07M derived: sum of 4 quarters · filed 2025-11-06 | |||
| 2024-06-30 | $280.00K 10-Q · filed 2025-08-07 | $445.00K 10-Q · filed 2025-08-07 | $591.00K derived: sum of 3 quarters · filed 2025-08-07 | $721.00K derived: sum of 4 quarters · filed 2025-08-07 | |||
| 2024-03-31 | $165.00K 10-Q · filed 2025-05-08 | $311.00K derived: sum of 2 quarters · filed 2025-05-08 | $441.00K derived: sum of 3 quarters · filed 2025-05-08 | $669.00K derived: sum of 4 quarters · filed 2025-05-08 | |||
| 2023-12-31 | $146.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $276.00K derived: sum of 2 quarters · filed 2025-03-03 | $504.00K derived: sum of 3 quarters · filed 2025-03-03 | $766.00K 10-K · filed 2025-03-03 | |||
| 2023-09-30 | $130.00K 10-Q · filed 2024-11-07 | $358.00K derived: sum of 2 quarters · filed 2024-11-07 | $620.00K 10-Q · filed 2024-11-07 | $915.00K derived: sum of 4 quarters · filed 2025-03-03 | |||
| 2023-06-30 | $228.00K 10-Q · filed 2024-08-07 | $471.00K 10-Q · filed 2024-08-07 | $785.00K derived: sum of 3 quarters · filed 2025-03-03 | $916.00K derived: sum of 4 quarters · filed 2025-03-03 | |||
| 2023-03-31 | $243.00K 10-Q · filed 2024-05-06 | $200.00K 10-Q · filed 2023-05-09 | $557.00K derived: sum of 2 quarters · filed 2025-03-03 | $688.00K derived: sum of 3 quarters · filed 2025-03-03 | $888.00K derived: sum of 4 quarters · filed 2025-03-03 | ||
| 2022-12-31 | $314.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $445.00K derived: sum of 2 quarters · filed 2025-03-03 | $645.00K derived: sum of 3 quarters · filed 2025-03-03 | $721.00K 10-K · filed 2025-03-03 | $700.00K 10-K · filed 2023-03-09 | ||
| 2022-09-30 | $131.00K 10-Q · filed 2023-11-09 | $100.00K 10-Q · filed 2022-11-08 | $331.00K derived: sum of 2 quarters · filed 2023-11-09 | $407.00K 10-Q · filed 2023-11-09 | $200.00K 10-Q · filed 2022-11-08 | $680.00K derived: sum of 4 quarters · filed 2024-02-27 | |
| 2022-06-30 | $200.00K 10-Q · filed 2022-08-08 | $300.00K 10-Q · filed 2022-08-08 | $549.00K derived: sum of 3 quarters · filed 2024-02-27 | $949.00K derived: sum of 4 quarters · filed 2024-02-27 | |||
| 2022-03-31 | $100.00K 10-Q · filed 2023-05-09 | $349.00K derived: sum of 2 quarters · filed 2024-02-27 | $749.00K derived: sum of 3 quarters · filed 2024-02-27 | $1.05M derived: sum of 4 quarters · filed 2024-02-27 | |||
| 2021-12-31 | $249.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $649.00K derived: sum of 2 quarters · filed 2024-02-27 | $949.00K derived: sum of 3 quarters · filed 2024-02-27 | $949.00K 10-K · filed 2024-02-27 | $900.00K 10-K · filed 2022-03-01 | ||
| 2021-09-30 | $400.00K 10-Q · filed 2022-11-08 | $700.00K derived: sum of 2 quarters · filed 2022-11-08 | $700.00K 10-Q · filed 2022-11-08 | ||||
| 2021-06-30 | $300.00K 10-Q · filed 2022-08-08 | $500.00K 10-Q · filed 2022-08-08 | |||||
| 2021-03-31 | $200.00K 10-Q · filed 2022-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |